Dec 19 (Reuters) - Bionomics Ltd (BNO) :
- REPORTS TOPLINE RESULTS IN PREVAIL PHASE 2 STUDY OF BNC210 IN SOCIAL ANXIETY DISORDER
- BNC210 FOR TREATMENT OF SOCIAL ANXIETY DISORDER DID NOT MEET PRIMARY ENDPOINT
News: BNO Bionomics Reports Topline Results In Prevail Phase 2 Study Of BNC210
Add to My Watchlist
What is My Watchlist?